会員登録
ログイン
【7776】セルシード
細胞シートによる再生医療。
売上高
営業利益
経常利益
当期利益
業績予想修正
対前回修正率
当初予想比較
| 決算期 | 日付 | 予・実 | 売上高 (百万円) | 対前回 | 営業利益 (百万円) | 対前回 | 経常利益 (百万円) | 対前回 | 当期利益 (百万円) | 対前回 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025.12 | 2025/02/13 | 当初予 | 195 | - | -1,010 | - | -1,010 | - | -1,060 | - |
| 2024.12 | 2025/02/13 | 実 | 193 | ↑ | -846 | ↑ | -847 | ↑ | -859 | ↑ |
| 2024.12 | 2024/11/14 | Q3予 | 170 | → | -920 | → | -920 | → | -940 | → |
| 2024.12 | 2024/08/13 | Q2予 | 170 | → | -920 | → | -920 | → | -940 | → |
| 2024.12 | 2024/05/13 | Q1予 | 170 | → | -920 | → | -920 | → | -940 | → |
| 2024.12 | 2024/02/13 | 当初予 | 170 | - | -920 | - | -920 | - | -940 | - |
| 2023.12 | 2024/02/13 | 実 | 190 | ↓ | -697 | ↑ | -710 | ↑ | -846 | ↓ |
| 2023.12 | 2023/11/14 | Q3予 | 200 | → | -840 | → | -840 | → | -845 | → |
| 2023.12 | 2023/08/14 | Q2予 | 200 | → | -840 | → | -840 | → | -845 | → |
| 2023.12 | 2023/05/15 | Q1予 | 200 | → | -840 | → | -840 | → | -845 | → |
| 2023.12 | 2023/02/14 | 当初予 | 200 | - | -840 | - | -840 | - | -845 | - |
| 2022.12 | 2023/02/14 | 実 | 126 | ↓ | -743 | ↑ | -754 | ↑ | -759 | ↑ |
| 2022.12 | 2022/11/14 | Q3予 | 209 | → | -834 | → | -834 | → | -838 | → |
| 2022.12 | 2022/08/12 | Q2予 | 209 | → | -834 | → | -834 | → | -838 | → |
| 2022.12 | 2022/05/12 | Q1予 | 209 | → | -834 | → | -834 | → | -838 | → |
| 2022.12 | 2022/02/14 | 当初予 | 209 | - | -834 | - | -834 | - | -838 | - |
| 2021.12 | 2022/02/14 | 実 | 161 | ↑ | -864 | ↓ | -887 | ↓ | -914 | ↓ |
| 2021.12 | 2021/12/15 | 修正予 | 160 | ↓ | -847 | ↑ | -869 | ↑ | -900 | ↑ |
| 2021.12 | 2021/11/11 | Q3予 | 213 | → | -976 | → | -998 | → | -998 | → |
| 2021.12 | 2021/08/12 | Q2予 | 213 | → | -976 | → | -998 | → | -998 | → |
| 2021.12 | 2021/05/13 | Q1予 | 213 | → | -976 | → | -998 | → | -998 | → |
| 2021.12 | 2021/02/12 | 当初予 | 213 | - | -976 | - | -998 | - | -998 | - |
| 2020.12 | 2021/02/12 | 実 | 199 | ↓ | -719 | ↑ | -744 | ↑ | -783 | ↓ |
| 2020.12 | 2020/11/12 | Q3予 | 200 | ↓ | -742 | ↑ | -751 | ↑ | -781 | ↑ |
| 2020.12 | 2020/07/16 | 修正予 | - | - | - | - | - | - | - | - |
| 2020.12 | 2020/05/14 | Q1予 | 310 | → | -1,020 | → | -1,020 | → | -1,020 | → |
| 2020.12 | 2020/02/14 | 当初予 | 310 | - | -1,020 | - | -1,020 | - | -1,020 | - |
| 2019.12 | 2020/02/14 | 実 | 275 | ↓ | -780 | ↑ | -786 | ↑ | -782 | ↑ |
| 2019.12 | 2019/11/14 | Q3予 | 300 | → | -1,100 | → | -1,100 | → | -1,100 | → |
| 2019.12 | 2019/08/14 | Q2予 | 300 | → | -1,100 | → | -1,100 | → | -1,100 | → |
| 2019.12 | 2019/05/14 | Q1予 | 300 | → | -1,100 | → | -1,100 | → | -1,100 | → |
| 2019.12 | 2019/02/15 | 当初予 | 300 | - | -1,100 | - | -1,100 | - | -1,100 | - |
| 2018.12 | 2019/02/15 | 実 | 1,026 | ↓ | 140 | ↑ | 140 | ↑ | 129 | ↑ |
| 2018.12 | 2018/11/13 | Q3予 | 1,170 | → | 20 | → | 50 | → | 40 | → |
| 2018.12 | 2018/08/14 | Q2予 | 1,170 | → | 20 | → | 50 | → | 40 | → |
| 2018.12 | 2018/05/15 | Q1予 | 1,170 | → | 20 | → | 50 | → | 40 | → |
| 2018.12 | 2018/02/14 | 当初予 | 1,170 | - | 20 | - | 50 | - | 40 | - |
| 2017.12 | 2018/02/14 | 実 | 85 | ↓ | -1,024 | ↑ | -964 | ↑ | -966 | ↑ |
| 2017.12 | 2017/11/13 | Q3予 | 100 | → | -1,250 | → | -1,230 | → | -1,230 | → |
| 2017.12 | 2017/05/12 | Q1予 | 100 | → | -1,250 | → | -1,230 | → | -1,230 | → |
| 2017.12 | 2017/02/16 | 当初予 | 100 | - | -1,250 | - | -1,230 | - | -1,230 | - |
| 2016.12 | 2017/02/16 | 実 | 100 | → | -1,413 | ↑ | -1,415 | ↑ | -1,414 | ↑ |
| 2016.12 | 2016/12/13 | 修正予 | 100 | → | -1,510 | ↓ | -1,500 | ↓ | -1,500 | ↓ |
| 2016.12 | 2016/11/14 | Q3予 | 100 | → | -1,200 | → | -1,150 | → | -1,150 | → |
| 2016.12 | 2016/05/13 | Q1予 | 100 | → | -1,200 | → | -1,150 | → | -1,150 | → |
| 2016.12 | 2016/02/16 | 当初予 | 100 | - | -1,200 | - | -1,150 | - | -1,150 | - |
| 2015.12 | 2016/02/16 | 実 | 193 | ↓ | -568 | ↑ | -531 | ↑ | -535 | ↑ |
| 2015.12 | 2015/12/24 | 修正予 | 200 | ↑ | -570 | ↑ | -550 | ↑ | -555 | ↑ |
| 2015.12 | 2015/05/15 | Q1予 | 90 | → | -1,100 | → | -1,085 | → | -1,090 | → |
| 2015.12 | 2015/02/16 | 当初予 | 90 | - | -1,100 | - | -1,085 | - | -1,090 | - |
| 2014.12 | 2015/02/16 | 実 | 86 | - | -601 | - | -577 | - | -582 | - |
| 2013.12 | 2014/02/14 | 実 | 105 | - | -534 | - | -581 | - | -584 | - |
